Hillsdale Investment Management Inc. Staar Surgical CO Transaction History

Hillsdale Investment Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$70.55 - $111.58 $515,015 - $814,534	7,300 New	7,300 $515,000
Q1 2022 Apr 28, 2022	SELL	$57.98 - $93.5 $429,052 - $691,900	-7,400 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$88.02 - $127.79 $70,416 - $102,232	-800 Reduced 9.76%	7,400 $676,000
Q3 2021 Oct 21, 2021	SELL	$122.75 - $162.68 $61,375 - $81,340	-500 Reduced 5.75%	8,200 $1.05 Million
Q2 2021 Jul 29, 2021	BUY	$105.76 - $154.96 $920,112 - $1.35 Million	8,700 New	8,700 $1.33 Million
Q2 2019 Aug 02, 2019	SELL	$23.08 - $37.01 $1.02 Million - $1.63 Million	-44,100 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$28.91 - $50.0 $86,730 - $150,000	3,000 Added 7.3%	44,100 $1.41 Million
Q3 2018 Nov 09, 2018	BUY	$30.85 - $50.65 $1.17 Million - $1.92 Million	38,000 Added 1225.81%	41,100 $1.97 Million
Q2 2018 Aug 13, 2018	BUY	$13.95 - $32.65 $43,245 - $101,215	3,100 New	3,100 $96,000

243

48.2M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $792M
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.